Posted on 31/05/2022
May 19, 2022 – Worthing-based Rayner, a global innovator in cataract and refractive surgery solutions and the only UK manufacturer of intraocular lenses (IOLs), announced today that AEON, its surgery-focused premium eye drops are now available in one of the leading UK optician chains, Boots Opticians, with more than 500 branches across the UK. In the UK,
Posted on 22/02/2022
FEBRUARY 22 2022 – Worthing, United Kingdom. Rayner, a global innovator in cataract and refractive surgery, announced today that it has agreed a development partnership with Wolffsohn Research Ltd to accelerate the development of its Digital Health platform. Rayner launched RayPRO, a digital platform to collect patient reported outcomes (PRO), in 2019 and has since collected data
Posted on 19/01/2022
JANUARY 19, 2022 – Worthing, United Kingdom. Rayner, a leading ophthalmology company and the only British manufacturer of intraocular lenses (IOLs), announced today that it now has a direct sales presence in Australia as it continues its global commercial expansion. Previously distributed through Designs For Vision, Rayner will now sell its products directly to surgeons and hospitals
Posted on 5/01/2022
JANUARY 05, 2022 – Worthing, United Kingdom. Rayner, the only UK manufacturer of intraocular lenses (IOLs), today announced the launch of RayOne Hydrophobic BLF. Made of its proprietary ultra glistening-free hydrophobic material, RayOne Hydrophobic BLF is Rayner’s first blue light filtering IOL. RayOne Hydrophobic BLF expands Rayner’s RayOne lens portfolio from seven to eight variants, now with
Posted on 22/12/2021
DECEMBER 22, 2021 – Worthing, United Kingdom. Rayner, a leading UK-based ophthalmic company focused on optimising visual outcomes for surgeons and their patients, is delighted to announce the appointment of Drs Eric Donnenfeld, Kerry Solomon, Vance Thompson, and Mr Jim Mazzo as strategic advisors to the business, with a specific focus on supporting the expansion
Posted on 2/12/2021
DECEMBER 02, 2021 – Worthing, United Kingdom. Rayner Surgical Group (‘Rayner’) and Omeros Corporation (‘Omeros’) are delighted to announce the transfer of Omeros’ ophthalmology assets, including OmidriaTM, to Rayner. This will enable the creation of a significant commercial, regulatory and marketing infrastructure in the US, with a broad range of products, including intraocular lenses (IOLs), for cataract surgeons.
Posted on 24/11/2021
NOVEMBER 24, 2021 – Worthing, United Kingdom. Rayner, a leading ophthalmology company focused on optimising visual outcomes for patients and surgeons, today announced the appointment of Dr Rob Nadler to the role of VP Corporate Development. Dr Nadler will play a critical role on the executive team, overseeing the company’s M&A strategy and brings invaluable clinical,
Posted on 4/08/2021
AUGUST 04, 2021 – Worthing, United Kingdom. Rayner, the pioneering manufacturer of intraocular lenses for cataract and refractive surgery, announced today that it has achieved the milestone figure of 1,000 intraocular lenses recorded on RayPRO, its digital patient reported outcomes platform. Launched at ASCRS in 2019 for ophthalmic surgeons who perform cataract procedures, RayPRO is
Posted on 18/06/2021
JUNE 18, 2021 – Worthing, United Kingdom. Rayner, the pioneering manufacturer of intraocular lenses for cataract and refractive surgery, announced today that it has acquired Surgicon Healthcare Pvt Limited in Mumbai, India. The acquisition closed on Friday 18th June 2021. Acquisition Details Rayner has acquired its exclusive Indian distributor, Surgicon, for an undisclosed price. The
Posted on 17/05/2021
New York, USA, May 17, 2021 – RayOne Spheric, a fully-preloaded monofocal IOL, has received FDA approval. This achievement marks Rayner’s third FDA approval in under three years within its expanding RayOne preloaded IOL portfolio. RayOne Spheric joins RayOne Aspheric (FDA approved December 2018) and RayOne EMV, a new non-diffractive IOL solution which achieved FDA